BackConstellation Pharmaceuticals Overview

Constellation Pharmaceuticals Total Liabilities

Latest total liabilities for CNST: $25M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$25.34M
55.96% YoYΔ $-32.20M vs prior year quarter

Peer average

Loading

Constellation Pharmaceuticals Total Liabilities History

Loading

Constellation Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Constellation Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Constellation Pharmaceuticals (CNST) FAQ

As of the most recent data (March 2021), CNST shows a total liabilities of $25M. That compares with $58M in the prior-year period — down 56.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CNST's total liabilities is now $25M (was $58M) — a 56.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Constellation Pharmaceuticals is outperforming or lagging.

Tracking CNST's total liabilities over time shows whether Constellation Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $25M That compares with $58M in the prior-year period — down 56.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Constellation Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $25M) with ownership activity and broader fundamentals.

Constellation Pharmaceuticals's total liabilities is $25M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.